{
    "id": 21877,
    "fullName": "ASXL1 inact mut",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "ASXL1 inact mut indicates that this variant results in a loss of function of the Asxl1 protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 171023,
        "geneSymbol": "ASXL1",
        "terms": [
            "ASXL1",
            "BOPS",
            "MDS"
        ]
    },
    "variant": "inact mut",
    "createDate": "04/29/2016",
    "updateDate": "07/30/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3320,
            "approvalStatus": "Clinical Study",
            "evidenceType": "Prognostic",
            "efficacyEvidence": "In multiple clinical studies, nonsense and frameshift mutations in ASXL1 were associated with decreased overall survival in patients with chronic myelomonocytic leukemia (PMID: 26849014, PMID: 23690417, PMID: 20880116).",
            "molecularProfile": {
                "id": 22424,
                "profileName": "ASXL1 inact mut"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 4972,
                "name": "myelodysplastic/myeloproliferative neoplasm",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 3731,
                    "pubMedId": 20880116,
                    "title": "ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20880116"
                },
                {
                    "id": 5278,
                    "pubMedId": 26849014,
                    "title": "Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26849014"
                },
                {
                    "id": 5343,
                    "pubMedId": 23690417,
                    "title": "Prognostic score including gene mutations in chronic myelomonocytic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23690417"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 22424,
            "profileName": "ASXL1 inact mut",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}